Home › Parkinson's Disease › NCT06467695

Low Voltage Electrical Stimulation for Depression in Parkinson's Patients

The Effect of MRI-Guided Transcranial Direct Current Stimulation on Cognitive and Affective Symptoms in Persons With Parkinson's Disease and Controls

Who can join

Ages 19 to 65 · All sexes

Inclusion Criteria:

* 19 to 65 years in age.
* Parkinson's Group must have a physician dx of Parkinson's Disease
* Must meet exhibit elevated levels of depression on the Beck Depression Inventory (scores of 20 or above).
* Must be willing and able to travel of the Psychology Department for EEG and tDCS sessions.
* Participants who have undergone surgery for Deep Brain Stimulation implantation may be enrolled if advised to and monitored by their physician.
* Read and understand spoken English.

Exclusion Criteria:

* No history of or being treated for epilepsy or other seizure disorders.
* No history of penetrating head wounds or TBI greater than mild TBI.
* No history of atypical Parkinson's

About the study

The goal of this clinical trial is to determine the relative efficacy of fMRI model guided Transcranial Direct Current Stimulation (mgTDCS) in improving the depressive symptoms of patients with Parkinson's Disease (PD). The main questions it aims to answer are: 1) Can the use of mgTDCS significantly improve the self-reported level of depression and apathy in patients with PD from pre-intervention to post-intervention compared to a sham control? 2) Can the use of mgTDCS significantly normalize the cortical eeg alpha asymmetry so commonly seen in depressed patients compared to sham mgTDCS? 3) Can the use of mgTDCS significantly improve scores on neuropsychological tests of working memory?

What is being tested

• BIOPAC Stimsola (device)
• BIOPAC Stimsola Sham (zero amps) (device)

Sponsor: University of South Alabama · Participants: 40 · Started: Aug 1, 2024

Contact the study team

• John F Shelley-Tremblay, PhD · Phone: 2514606883
• Benjamin D Hill, PhD · Phone: 251-460-6546

Official record on ClinicalTrials.gov — NCT06467695

Locations in the U.S.

Conditions

• Parkinson's Disease
• Depression

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.